ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

12 links0 made here, not in the record21 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07431281Sonesitatug Vedotin inCombination WithCapecitabine With orWithout Rilvegostomig inParticipants With Advancedor Metastatic Gastric,Gastroesophageal Junction,AstraZenecaPhase 3 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 16 · ClinicalTrials.gov record · Version of 2026-10-16Version of 2026-10-16CONDITIONSStomach NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termAs of now · Rule based · Main conditionMain conditionEsophageal NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Wider: a narrower term is filedWider: a narrower term is filedAdenocarcinomaThe registry's MeSH filing›Nov 14 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseAdenocarcinoma Of EsophagusThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termDRUGSSonesitatug vedotinIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedRilvegostomigIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedNivolumabIntervention entry›Nov 2 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partnerCapecitabineIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundFluorouracilEntry “5-Fluorouracil”, read by our n…›Nov 2 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorOxaliplatinIntervention entry›Nov 2 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorZolbetuximabIntervention entry›Nov 2 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorLeucovorinIntervention entry›Nov 2 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparator

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Sonesitatug vedotin

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Sonesitatug vedotin”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Oct 16The record itselfClinicalTrials.gov recordVersion of 2026-10-16Record change
Nov 2Sonesitatug vedotinClaude Opus 5.5TestedCurrent
Nov 2RilvegostomigClaude Opus 5.5TestedCurrent
Nov 2NivolumabClaude Opus 5.5Background · partnerCurrent
Nov 2CapecitabineClaude Opus 5.5BackgroundCurrent
Nov 2FluorouracilClaude Opus 5.5ComparatorCurrent
Nov 2OxaliplatinClaude Opus 5.5ComparatorCurrent
Nov 2ZolbetuximabClaude Opus 5.5ComparatorCurrent
Nov 2LeucovorinClaude Opus 5.5ComparatorCurrent
Nov 14Stomach NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Esophageal NeoplasmsRule based · condition-kind ruleWider: a narrower term is filedCurrent
Nov 14AdenocarcinomaRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 14Adenocarcinoma Of EsophagusRule based · condition-kind ruleFinest filed termCurrent
Nov 18Sonesitatug vedotinRule based · role ruleTestedAgrees
Nov 18RilvegostomigRule based · role ruleTestedAgrees
Nov 18NivolumabRule based · role ruleBackgroundAgrees
Nov 18CapecitabineRule based · role ruleBackgroundAgrees
Nov 18FluorouracilRule based · role ruleComparatorAgrees
Nov 18OxaliplatinRule based · role ruleComparatorAgrees
Nov 18ZolbetuximabRule based · role ruleComparatorAgrees
Nov 18LeucovorinRule based · role ruleComparatorAgrees
As of nowStomach NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.